Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

24 Apr 2023 12:51

RNS Number : 2549X
Maven Income and Growth VCT 3 PLC
24 April 2023
 

 

Maven Income and Growth VCT 3 PLC (the Company)

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at Kintyre House, 205 West George Street, on Monday 24 April 2023 at 12 noon, all of the Resolutions put to the Meeting were passed.

 

At the record date for the Annual General Meeting, being 20 April 2023, the total number of voting rights in the Company stood at and the total shares in issue were 113,495,613. The Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 6,491,022 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Directors' Report and audited Financial Statements

6,293,141

173,122

13,995

10,764

6,491,022

2

To approve the Directors' Remuneration Report

6,038,582

232,128

162,013

58,299

6,491,022

3

To approve the Directors' Remuneration Policy

5,788,540

247,253

268,580

186,649

6,491,022

4

To approve a final dividend payment

6,297,123

162,876

20,097

10,926

6,491,022

5

To re-elect Atul Devani as a Director

6,111,108

228,663

75,600

75,651

6,491,022

6

To re-elect David Allan as a Director

6,145,552

225,008

56,256

64,206

6,491,022

7

To re-elect Bill Nixon as a Director

6,125,828

238,656

68,740

57,798

6,491,022

8

To re-elect Keith Pickering as a Director

6,153,750

234,550

38,516

64,206

6,491,022

9

To appoint Johnston Carmichael LLP as Auditor

6,187,937

184,091

57,605

61,389

6,491,022

10

To authorise the Directors to fix the remuneration of the Auditor

6,256,536

179,224

42,525

12,737

6,491,022

11

To authorise the Directors to allot new shares

5,688,278

180,306

531,736

90,702

6,491,022

12

To authorise disapplication of pre-emption rights

5,437,776

163,876

844,717

44,653

6,491,022

13

To authorise the Company to purchase its own shares

5,589,688

163,876

732,634

4,824

6,491,022

14

To allow a General Meeting to be called on not less than 14 days' notice

5,970,210

186,185

298,509

36,118

6,491,022

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures, along with a summary of questions submitted to the AGM and the Board's responses to them, will be available to view at: www.mavencp.com/migvct3.

 

A copy of the Resolutions passed at the 2023 AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

 

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

24 April 2023

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKQBQDBKDCQB
Date   Source Headline
26th Jul 201911:25 amRNSHalf-year Report
10th Jul 20195:03 pmRNSTransaction in Own Shares
2nd Jul 20194:20 pmRNSUnaudited Net Asset Value and Interim Dividend
28th May 20193:13 pmRNSTransaction in Own Shares
11th Apr 201910:53 amRNSNet Asset Value(s)
10th Apr 201912:49 pmRNSResult of AGM
1st Mar 20193:01 pmRNSAnnual Financial Report
7th Feb 20194:34 pmRNSTransaction in Own Shares
17th Jan 20193:06 pmRNSNet Asset Value(s)
27th Nov 20182:42 pmRNSTransaction in Own Shares
21st Nov 20184:03 pmRNSNet Asset Value(s)
20th Jul 20184:04 pmRNSHalf-year Report
17th Jul 20184:09 pmRNSTransaction in Own Shares
3rd Jul 20184:30 pmRNSNet Asset Value(s)
22nd Jun 20184:30 pmRNSIssue of Equity
15th Jun 20184:49 pmRNSStatement re DIS
17th May 20184:30 pmRNSDividend Declaration
26th Apr 20189:35 amRNSDirector/PDMR Shareholding
24th Apr 20184:51 pmRNSIssue of Equity
16th Apr 20185:12 pmRNSNet Asset Value(s)
13th Apr 201812:47 pmRNSIssue of Equity
13th Apr 201811:59 amRNSPublication of Suppl.Prospcts
11th Apr 20181:12 pmRNSResult of AGM
6th Apr 20184:38 pmRNSStatement re Dividend Investment Scheme
6th Apr 20189:21 amRNSDirector/PDMR Shareholding
5th Apr 20186:22 pmRNSIssue of Equity
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
9th Mar 20184:16 pmRNSAnnual Financial Report
8th Mar 20183:30 pmRNSDividend Declaration
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
13th Feb 20183:34 pmRNSTransaction in Own Shares
6th Feb 20185:14 pmRNSDirector/PDMR Shareholding
6th Feb 20185:13 pmRNSDirector/PDMR Shareholding
6th Feb 20185:12 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:41 pmRNSPublication of Suppl.Prospcts
19th Jan 20183:33 pmRNSNet Asset Value(s)
30th Nov 20174:31 pmRNSIssue of Equity
22nd Nov 20175:06 pmRNSTransaction in Own Shares
21st Nov 20173:45 pmRNSIssue of Equity
17th Nov 20175:05 pmRNSStatement re NAV and Dividend Investment Scheme
8th Nov 201710:11 amRNSResult of General Meeting
27th Oct 20173:26 pmRNSNet Asset Value(s)
25th Oct 20172:57 pmRNSDividend Declaration
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:45 pmRNSIssue of Equity
15th Sep 201710:05 amRNSStatement re NAV and Dividend Investment Scheme
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
31st Aug 20175:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.